Low-dose cohort data reported from phase I/II study of AXO-AAV-GM1 for GM1 gangliosidosis Dec. 16, 2020
First phase III study of dasiglucagon in congenital hyperinsulinism does not meet primary endpoint Dec. 16, 2020
Leqvio approved in Europe for the treatment of hypercholesterolemia or mixed dyslipidemia Dec. 14, 2020
Passage Bio receives first clearance for PBGM-01 clinical trial program for GM1 gangliosidosis Dec. 11, 2020
ObsEva reports further phase III data on use of linzagolix for bleeding due to uterine fibroids Dec. 10, 2020
RSS